Stephen Basso, MBA
Vice President of Finance
Stephen Basso joined Inozyme Pharma in October 2017 as Vice President of Finance, bringing a track record of more than 25 years of finance experience in both the financial services and life sciences industries. Prior to joining Inozyme Pharma, Mr. Basso served as Vice President of Corporate Finance at Alexion Pharmaceuticals, where he built and led the corporate finance function and established the organization’s global financial planning & analysis team. During his tenure, the organization commercialized three products (eculizumab, asfotase alfa, and (sebelipase alfa) across a 50-country commercial platform.
Additionally, Mr. Basso has held multiple leadership roles at Pfizer, where he led the R&D integration of Pharmacia, combining the product portfolios and global development infrastructure. Mr. Basso earned a B.S. in business from Providence College and an MBA from Boston College.